ReviewBiomimetics (Basel, Switzerland)2026
Standardizing TEER Measurements in Blood-Brain Barrier-on-Chip Systems: A Systematic Review of Electrode Designs and Configurations.
Review in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Tau Oligomers Induce Brain Endothelial Cell Hyperpermeability and Increase NLRP3 Inflammasome Signaling and MMP-9 Activity.Microcirculation (New York, N.Y. : 1994) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The blood-brain barrier (BBB) is one of the most selective physiological interfaces in the human body. Transendothelial electrical resistance (TEER) has become a widely adopted quantitative metric for assessing its in vitro structural and functional integrity. Although TEER measurements are routinely incorporated into BBB-on-chips, the absence of harmonized electrode architectures, measurement settings, and reporting standards continues to undermine reproducibility and translational reliability among laboratories. This systematic review provides the first comprehensive classification and critical comparison of electrode configurations used for TEER assessment, specifically within BBB-on-chip systems. Eligible studies were analyzed and categorized according to electrode design, fabrication method, integration strategy, and operational constraints. We critically evaluated six principal electrode architectures, highlighting their performance trade-offs in terms of uniformity of current distribution, long-term stability, scalability, and compatibility with dynamic shear conditions. Furthermore, we propose a bioinspired TEER reporting framework that consolidates essential metadata, including electrode specification, temperature control, viscosity effects, and blank resistance correction. Our analysis proposes screen-printed and hybrid silver-indium tin oxide (ITO) electrodes as promising candidates for next-generation BBB platforms. Moreover, our review provides a structured roadmap for standardizing TEER electrode design and reporting practices to facilitate interlaboratory consistency and accelerate the adoption of BBB-on-chip systems as truly biomimetic platforms for predictive neuropharmacological workflows.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.